CERT stock forecast
Our latest prediction for Certara Inc's stock price was made on the Sept. 22, 2021 when the stock price was at 36.00$.
In the short term (2weeks), CERT's stock price should underperform the market by -1.53%. During that period the price should oscillate between -8.50% and +7.40%.
In the medium term (3months), CERT's stock price should underperform the market by -4.92%. During that period the price should oscillate between -27.48% and +18.32%.Get email alerts
Create a solid portfolio with CERT
About Certara Inc
Certara optimizes R&D productivity, commercial value and patient outcomes through its unique portfolio of model-informed drug development, regulatory science, and market access solutions. In fact, 90+% of all novel drugs approved by the US FDA in the past six years were supported by Certara software or services. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
At the moment the company generates 262M USD in revenues.
On its last earning announcement, the company reported a loss of -0.36$ per share.
The book value per share is 3.25$
Three months stock forecastSept. 22, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|